Nature Medicine | Spoonful of Medicine

Q&A: A healthy chat with the Center for Global Development’s health policy leader

nm1211-1534-I1.jpgSince its launch in 2001, the Center for Global Development (CGD) has been instrumental in convening working groups and issuing reports that shape the agenda for a range of topics that affect global poverty and people of the developing world. At the helm of its global health effort is Amanda Glassman. As the daughter of US Foreign Service diplomats, Glassman was exposed to disparities in public health in developing countries from a very young age. So it was a no-brainer for Glassman that she would devote her career to tackling those inequalities. She has spent the last two decades at places like the US Agency for International Development, the Inter-American Development Bank and the Brookings Institution. Last year, she joined CGD as the director of its global health policy division.

One idea that the $10-million-a-year, Washington, DC–based think tank has championed with some success is what’s known as an advance market commitment (AMC), a financial instrument that incentivizes vaccine development for diseases primarily affecting low-income countries. It’s for this influence that the center, which is mainly funded by governments and philanthropic entities, was ranked the fifteenth most important US think tank by Foreign Policy magazine in 2008. In recognition of CGD’s ten-year anniversary last month, Elie Dolgin spoke to Glassman about how the think tank turns its words into actions.

(Click here to continue reading.)

Comments

There are currently no comments.